- Home
- GENB vs BHC Comparison
GENB vs BHC Comparison
Compare GENB & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GENB | BHC |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2026 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GENB | BHC |
|---|---|---|
| Price | $15.91 | $5.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $23.20 | $8.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $16.58 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.00 | $4.33 |
| 52 Week High | $22.67 | $8.00 |
Technical Indicators
Market Signals| Indicator | GENB | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.75 | 40.44 |
| Support Level | $11.82 | $5.42 |
| Resistance Level | $16.75 | $5.96 |
| Average True Range (ATR) | 0.87 | 0.21 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 41.84 | 11.59 |
Price Performance
Historical ComparisonAbout GENB Generate Biomedicines Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.